InflaRx Looks Ahead To Late 2023 Commercial Sales For COVID-19 Antibody

Gohibic Cleared Under EUA

 
• By Alaric DeArment
  
InflaRx received an EUA from the FDA for Gohibic • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip